CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.

1:14-cv-00917

Overview

Case Number 1:14-cv-00917
Filing Date 2014-07-11
Status Terminated
Termination Date 2016-08-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Ascend Laboratories LLC Operating Company

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Acorda Therapeutics Inc. Operating Company

Represented By

6 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jeffrey Martin

Email: jeffrey.martin@apks.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Soumitra Deka

Email: sam.deka@dlapiper.com

Daniel P. DiNapoli

Email: daniel.dinapoli@apks.com

Aaron Stiefel

Email: aaron.stiefel@apks.com

Alkermes Pharma Ireland Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Alkem Laboratories Ltd. Operating Company

Represented By

6 Attorneys Listed

Imron T. Aly

Email: ialy@schiffhardin.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

Alison L. Maddeford

Email: amaddeford@rshc-law.com

A. Taylor Corbitt

UNDELIVERABLE EMAIL 3/7/2016

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 5 proceedings
🏛️
USPTO PTAB Trials 6 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (11 found):
PTAB: 6 U.S. Courts: 5
USPTO PTAB Trial 2015-09-03
IPR2015-01858

Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2015-09-03
IPR2015-01857

Coalition For Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

U.S. Continuation Sibling (8663685)
Status: Final Written Decision
USPTO PTAB Trial 2015-09-02
IPR2015-01853

Coalition For Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

U.S. Continuation Sibling (8007826)
Status: Final Written Decision
USPTO PTAB Trial 2015-09-02
IPR2015-01850

Coalition For Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

U.S. Continuation Sibling (8440703)
Status: Final Written Decision
USPTO PTAB Trial 2015-02-27
IPR2015-00817

Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

U.S. Continuation Sibling (8007826)
Status: Institution Denied
USPTO PTAB Trial 2015-02-10
IPR2015-00720

Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc.

U.S. Continuation Sibling (8663685)
Status: Institution Denied
U.S. District Court 2015-09-15
1:15-cv-00824

Acorda Therapeutics Inc. v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-05-15
1:15-cv-00391

Acorda Therapeutics Inc. v. Sun Pharmaceutical Industries Limited

Asserted Patent
Status: DED
U.S. District Court 2014-07-18
1:14-cv-00955

Acorda Therapeutics Inc. v. Apotex Corp.

Asserted Patent
Status: DED
U.S. District Court 2014-07-16
1:14-cv-00935

Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-15
1:14-cv-00932

Acorda Therapeutics Inc. v. Accord Healthcare Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5540938
Formulations and their use in the treatment of neurological diseases
Filed: 1994-10-24
Issued: 1996-07-30
Expired (Term Ended) +1375d PTA
Expires: 2018-07-30
US8007826
Sustained release aminopyridine composition
Filed: 2004-12-13
Issued: 2011-08-30
Active (0.5 yrs remaining) +894d PTA
Expires: 2027-05-26
US8354437
Method of using sustained release aminopyridine compositions
Filed: 2005-04-08
Issued: 2013-01-15
Active (1.4 yrs remaining) +1119d PTA
Expires: 2028-05-01
US8440703
Methods of using sustained release aminopyridine compositions
Filed: 2011-11-18
Issued: 2013-05-14
Active (5.0 yrs remaining)
Expires: 2031-11-18
US8663685
Sustained release aminopyridine composition
Filed: 2011-07-20
Issued: 2014-03-04
Expired (Term Ended)
Expires: 2025-02-26

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1375 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 1 Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These case are CONSOLIDATED for all purposes and all papers shall be f...
Entry #26 • 2015-04-22 Document →
Claim Construction / Markman Filing Pending / Under Review
ORAL ORDER: Having reviewed the parties' letter of April 8 (C.A. No. 14-882 D.I. 26), and having had a trial slot in September 2016 open up (subsequent to the s...
Entry #23 • 2015-04-13 Document →
Claim Construction / Markman Filing Pending / Under Review
Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding the parties' respective positions regarding the scheduling of Markman hearing and trial ...
Entry #22 • 2015-04-08 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to August 8, 2014 - filed by Alkem Laboratories Ltd., Ascend Laboratories LLC. (Phi...
Entry #8 • 2014-08-01 Document →

Docket Entries

(35 total)
Pleading / Complaint

COMPLAINT filed against Alkem Laboratories Ltd., Ascend Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1551845.) - filed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. (Attachments: # 1 Exhibit A - E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 07/11/2014)

Entry #1 • 2014-07-11
1
Pleading / Complaint

COMPLAINT filed against Alkem Laboratories Ltd., Ascend Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1551845.) - filed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. (Attachments: # 1 Exhibit A - E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 07/11/2014)

Entry #1 • 2014-07-11
2
Pleading / Complaint

COMPLAINT filed against Alkem Laboratories Ltd., Ascend Laboratories LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1551845.) - filed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. (Attachments: # 1 Exhibit A - E, # 2 Civil Cover Sheet)(dmp, ) (Entered: 07/11/2014)

Entry #1 • 2014-07-11
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 07/11/2014)

Entry #2 • 2014-07-11
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 07/02/2014. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 7/22/2017. (dmp, ) (Entered: 07/11/2014)

Entry #3 • 2014-07-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc